Micronized dehydrated human amniotic/chorionic membrane improves plantar fasciitis pain .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2014;2(1):7 Foot Ankle Int. 2013 Oct;34(10):1332-945 patients with plantar fasciitis (8 weeks to 1 year duration of symptoms) were randomized to evaluate the efficacy of micronized dehydrated human amniotic/chorionic membrane (mDHACM) in the treatment of refractory plantar fasciitis over 8 weeks. Reduction of symptoms was evaluated by The American Orthopaedic Foot and Ankle Society (AOFAS) Hindfoot scale; the Wong-Baker FACES Pain Rating Scale; and QualityMetric’s SF-36v2 Standard Health Survey. The evidence presented in this study demonstrated that plantar fasciitis symptoms were significantly and equally improved for patients administered with 0.5cc mDHACM or with 1.25cc mDHACM within 1 week of intervention. No treatment-related adverse events were observed throughout 8 weeks of study.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
